www.drugs.com

Share

www.drugs.com

 •  September 25

September 25, 2017 -- The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved versions of prescription medicines, including opioids, antibiotics and injectable epinephrine products to...

www.drugs.com

 •  September 6

Audience: Internal Medicine, Nephrology, Cardiology, Pharmacy ISSUE: FDA is recommending that patients avoid taking the potassium-lowering drug sodium polystyrene sulfonate (Kayexalate) at the same time as other medicines taken by mouth. A study found that sodium polystyrene sulfonate binds to many commonly prescribed oral medicines, decreasing the...

www.drugs.com

 •  July 26

WATERTOWN, Mass., July 25, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced positive top-line results from IGNITE4, the Company's phase 3 clinical trial evaluating the...

www.drugs.com

 •  May 17

prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration now says. The FDA is requiring the medications to carry new warnings about the risk. The required warnings on the drug's labeling include the most serious and prominent boxed...

www.drugs.com

 •  April 21

Audience: Pharmacy, Patient ISSUE: C.O. Truxton, Inc. is voluntarily recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg, to the consumer/user level. The manufacturer received a confirmed customer complaint that a bottle labeled as phenobarbital 15 mg was found to contain phenobarbital 30 mg tablets. This mislabeled product could expose the...

www.drugs.com

 •  April 20

Audience: Pediatrics, OB/GYN, Internal Medicine ISSUE: FDA is restricting the use of codeine and tramadol medicines in children. These medicines carry serious risks, including slowed or difficult breathing and death, which appear to be a greater risk in children younger than 12 years, and should not be used in these children. These medicines should...

www.drugs.com

 •  April 13

Probably lots of them. Clinical research trials are performed in children to develop age-specific treatments, and to assess the safety and/or effectiveness of drugs and vaccines in their smaller bodies. Participation is voluntary. Depending on the type of trial and product evaluated, participants may receive an experimental drug, a proven...